Gilead to lay off 66 in office consolidation

Gilead Sciences is laying off up to 66 people as it closes its offices in Boulder and Westminster, Colorado, to consolidate its operations in California; the company hopes to relocate 73 of its 139 Colorado employees. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.